Safety Shot, Inc. (SHOT)
NASDAQ: SHOT · Real-Time Price · USD
0.3805
-0.0430 (-10.15%)
Oct 9, 2025, 3:49 PM EDT - Market open
Company Description
Safety Shot, Inc. provides over-the-counter products and consumer products in the United States.
The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content.
It also provides hair loss treatment, vitiligo solution, eczema cream, and sexual wellness products. It sells its products through direct customers, distributors, retailers, and e-commerce websites.
The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023.
Safety Shot, Inc. was incorporated in 2018 and is based in Jupiter, Florida.
Safety Shot, Inc.
| Country | United States |
| Founded | 2018 |
| IPO Date | Oct 30, 2020 |
| Industry | Beverages - Non-Alcoholic |
| Sector | Consumer Staples |
| Employees | 8 |
| CEO | Jarrett Boon |
Contact Details
Address: 1061 East Indiantown Road, Suite 110 Jupiter, Florida 33477 United States | |
| Phone | 561 244 7100 |
| Website | safetyshotofficial.com |
Stock Details
| Ticker Symbol | SHOT |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $7.50 |
| CIK Code | 0001760903 |
| CUSIP Number | 48208F105 |
| ISIN Number | US48208F1057 |
| Employer ID | 83-2455880 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Jarrett A. Boon | Chief Executive Officer and Director |
| Jordan Schur | President and Director |
| David Sandler CSCS, FISSN, FNSCA, HFD, HFS, M.S., MS, RSCC | Consultant |
| Markita L. Russell | Chief Financial Officer |
| Anthony Pedicelli | Director of Marketing |
| Dr. Andy Goren M.D. | Chief Medical Officer and Member of Scientific Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 8, 2025 | 8-K | Current Report |
| Oct 6, 2025 | DEF 14A | Other definitive proxy statements |
| Sep 30, 2025 | SCHEDULE 13D | Filing |
| Sep 26, 2025 | PRER14A | Filing |
| Sep 23, 2025 | SCHEDULE 13D | Filing |
| Sep 9, 2025 | 8-K | Current Report |
| Sep 4, 2025 | 8-K | Current Report |
| Aug 29, 2025 | 8-K | Current Report |
| Aug 29, 2025 | PRE 14A | Other preliminary proxy statements |
| Aug 29, 2025 | 424B5 | Filing |